Key Takeaways
- PorMedTec Co. plans to start clinical trials for pig-to-human kidney transplantation in Japan by 2028.
- The trials will take place at Hokkaido University Hospital and Shonan Kamakura General Hospital.
- This xenotransplantation initiative aims to alleviate the shortage of donor organs in Japan.
Details on the Initiative
Japanese biotechnology startup PorMedTec Co. announced its intention to lead Japan’s first clinical trials involving pig-to-human kidney transplantation, slated to commence as early as 2028. The trials will take place at two hospitals: Hokkaido University Hospital, located in the northern region of Hokkaido, and Shonan Kamakura General Hospital in Kanagawa Prefecture, situated south of Tokyo.
This groundbreaking approach, known as xenotransplantation, involves transplanting animal organs into humans, a process that hopes to mitigate the ongoing shortage of human donor organs. The initiative is significant as Japan faces a growing need for transplantable organs, often leaving many patients awaiting life-saving procedures.
PorMedTec, which originated from Meiji University, aims to secure both manufacturing and marketing approvals following the successful demonstration of safety through these clinical trials. The company has partnered with an American startup, eGenesis, to import genetically modified pig cells. These cells will be utilized to breed cloned pigs specifically for organ transplantation, ensuring they meet necessary safety requirements.
The potential for xenotransplantation to revolutionize organ donation is immense, as it not only provides an alternative source for organs but also addresses the lengthy waiting periods experienced by patients. The preliminary focus on kidneys highlights the urgent demand for this type of organ, which is critical for individuals with renal failure.
As the planned trials approach, the medical community and prospective patients alike are closely monitoring developments in this innovative field. If successful, PorMedTec’s efforts could pave the way for expanded use of xenotransplantation, potentially transforming the landscape of organ transplants in Japan and beyond.
The content above is a summary. For more details, see the source article.